USPSTF found insufficient evidence on the benefits and harms of screening adults ≥50 y for AF
Authors: Sylvia E. Choi, Gregory Y.H. Lip
Journal: Annals of Internal Medicine (2022)

ACP Journal ClubJune 2022USPSTF found insufficient evidence on the benefits and harms of screening adults ≥50 y for AFSylvia E. Choi, MBBS, Gregory Y.H. Lip, MDSylvia E. Choi, MBBSLiverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, UK (S.E.C., G.Y.L.)Search for more papers by this author, Gregory Y.H. Lip, MDLiverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, UK (S.E.C., G.Y.L.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/J22-0036 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Source CitationDavidson KW, Barry MJ, Mangione CM, et al. Screening for atrial fibrillation: US Preventive Services Task Force recommendation statement. JAMA. 2022;327:360-7. https://pubmed.ncbi.nlm.nih.gov/35076659Clinical Impact RatingsGIM/FP/GP: Cardiology: References1. Andrade JG, Aguilar M, Atzema C, et al. The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol. 2020;36:1847-948. [PMID: 33191198] Google Scholar2. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42:373-498. [PMID: 32860505] Google Scholar3. Wallenhort C, Martinez C, Freedman B. Risk of ischemic stroke in asymptomatic atrial fibrillation incidentally detected in primary care compared with other clinical presentations. Thromb Haemost. 2022;122:277-85. [PMID: 34192776] Google Scholar4. Mahaan R, Perera T, Elliott AD, et al. Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis. Eur Heart J. 2018;39:1407-15. [PMID: 29340587] Google Scholar5. Mairesse GH, Moran P, Van Gelder IC, et al. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). Europace. 2017;19:1589-623. [PMID: 29048522] Google Scholar6. Chao TF, Joung B, Takahashi Y, et al. 2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary. Thromb Haemost. 2022;122:20-47. [PMID: 34773920] Google Scholar7. Romiti GF, Pastori D, Rivera-Caravaca JM, et al. Adherence to the ‘Atrial Fibrillation Better Care’ pathway in patients with atrial fibrillation: impact on clinical outcomes. Thromb Haemost. 2022;122:406-14. [PMID: 34020488] Google Scholar Author, Article, and Disclosure InformationAffiliations: Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool, UK (S.E.C., G.Y.L.)Disclosures: The commentators have reported no disclosures of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=J22-0036.This article was published at Annals.org on 7 June 2022.ACP Journal Club is editorially independent from Annals of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics June 2022Volume 175, Issue 6Page: JC62KeywordsAnticoagulant therapyAtrial fibrillationHemorrhagic strokeIschemic strokeOdds ratioRandomized trialsResearch quality assessmentStrokeSystematic reviewsTransient ischemic attacks ePublished: 7 June 2022 Issue Published: June 2022 Copyright & PermissionsCopyright © 2022 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...